New changes to Canada’s drug patent regulations will revive 2006-era rules after Federal Court judgments narrowed patent law. Industry Canada said it feared numerous drug patents would lapse without a change in regulations: “It’s back to the future”.
This content is for Blacklock’s Reporter members only. Please login to view this content. (Register here.)
